Actually, it is known that in postmenopausal women low plasma levels of adiponectin may be associated with increased prevalence of metabolic syndrome, osteoporosis, and obesity [21], but no studies have evaluated, during this period, the likely relationship about serum adiponectin levels and cognitive performance. This evidence concerns the gene ADIPOQ and obesity due to melanocortin 4 receptor deficiency.